Cancer Surgery Imaging Agents
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
124
NCT05900986
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 14, 2023
Completion: May 31, 2026
NCT06713564
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
Phase: Phase 1
Start: Nov 7, 2024
Completion: Oct 31, 2025
Loading map...